Dynavax Technologies | SKULD



Debt Ändra Datum
AbbVie USD 67.14B 3.94B 2024-12
Adma Biologics USD 72.34M 28.99M 2024-12
Amgen USD 57.38B 2.72B 2025-03
AstraZeneca USD 31.65B 1.35B 2025-03
Biogen USD 6.3B 2M 2025-03
BioMarin Pharmaceutical USD 595.65M 585K 2025-03
Bristol-Myers Squibb USD 49.71B 62M 2025-03
Dynavax Technologies USD 260.51M 36.65M 2025-03
Gilead Sciences USD 26.71B 3.46B 2024-12
Glaxosmithkline GBP 16.99B 927M 2024-12
Merck USD 34.84B 2.27B 2025-03
Neurocrine Biosciences USD 0 0 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 62.11B 2.24B 2025-03
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 34.44B 5.23B 2024-06
Sarepta Therapeutics USD 1.14B 1.16M 2025-03
TG Therapeutics USD 244.43M 271K 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12



Dynavax Technologies SKULD - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - May 2025.